05 Feb 2025
// PR NEWSWIRE
24 Jan 2025
// PR NEWSWIRE
18 Nov 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
Reset all filters
01 2ACITRETIN
02 3ASENAPINE MALEATE
03 2ASPIRIN; BUTALBITAL; CAFFEINE
04 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
05 2Atropine
06 1BEZAFIBRATE
07 2BRIMONIDINE TARTRATE
08 9Bimatoprost
09 1Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride
10 3Brimonidine Tartrate
11 2CHLORAMPHENICOL
12 1CHLORAMPHENICOL; PREDNISOLONE
13 1CROMOLYN SODIUM
14 1CYCLOSPORINE
15 1Clostridium botulinum neurotoxin typ A
16 3Clostridium botulinum neurotoxin type A
17 1Cyclopentolate
18 1DEXAMETHASONE
19 2DICYCLOMINE HYDROCHLORIDE
20 3DILTIAZEM HYDROCHLORIDE
21 1DIPIVEFRIN HYDROCHLORIDE
22 1Deoxycholic Acid
23 4Dexamethasone
24 1EPINASTINE HYDROCHLORIDE
25 1ESTRADIOL
26 4ETHINYL ESTRADIOL; NORETHINDRONE
27 1ETHOXZOLAMIDE
28 1Epinastine
29 1FERRIC OXYHYDROXIDE
30 4FLUOCINOLONE ACETONIDE
31 1FLUOROMETHOLONE
32 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
33 1FLURBIPROFEN SODIUM
34 1Flurbiprofen
35 1GATIFLOXACIN
36 1GENTAMICIN SULFATE
37 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
38 5HYDROCORTISONE
39 2HYDROXYPROGESTERONE CAPROATE
40 1IDOXURIDINE
41 1KETOROLAC TROMETHAMINE
42 1Ketorolac Tromethamine
43 1Ketorolac tromethamine
44 2LEVOBUNOLOL HYDROCHLORIDE
45 6LIOTRIX (T4;T3)
46 3Levobunolol
47 2Levobunolol hydrochloride
48 2Linaclotide
49 1MEDRYSONE
50 1MEMANTINE HYDROCHLORIDE
51 12MORPHINE SULFATE
52 1NAPHAZOLINE HYDROCHLORIDE
53 4NEBIVOLOL HYDROCHLORIDE
54 1NEDOCROMIL SODIUM
55 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
56 1OFLOXACIN
57 2OXYBUTYNIN
58 2Ofloxacin
59 5OnabotulinumtoxinA
60 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
61 1PODOFILOX
62 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
63 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
64 1PROPARACAINE HYDROCHLORIDE
65 2Pilocarpine
66 1Progesterone
67 1SELENIUM SULFIDE
68 3SULFACETAMIDE SODIUM
69 3Several substances refer to content
70 5TAZAROTENE
71 2TRETINOIN
72 1TRIAMCINOLONE ACETONIDE
73 3TRIMEPRAZINE TARTRATE
74 2TROSPIUM CHLORIDE
75 2Tazarotene
76 6Timolol
77 2Timolol; Bimatoprost
78 1Timolol; Brimonidine
79 2URSODIOL
80 3bimatoprost
81 1brimonidine tartrate
82 2carmellose
83 1dexametason
84 1epinastine hydrochloride
85 1pirenoxine
Reset all filters
01 98ALLERGAN
02 14ALLERGAN HERBERT
03 3ALLERGAN INC
04 1ALLERGAN PHARMACEUT.INTERN.LTD
05 8ALLERGAN PHARMACEUTIC.IRELAND
06 14ALLERGAN SpA
07 5Allergan Pharmaceuticals (Pty) Ltd
08 12Allergan Pharmaceuticals Ireland
09 2Allergan Solvay International Limited
10 2Allergan Solvay International Ltd. (1)
11 15Allergan Solvay Ireland Ltd
12 3Allergan, Inc. Waco
Reset all filters
01 2AEROSOL;TOPICAL
02 1Bimatoprost 0,3Mg/Ml 0.4 Ml 30Units Solution Ophthalmic Use
03 1Bimatoprost 0,3Mg/Ml 3Ml Solution Ophthalmic Use
04 1Bimatoprost 0.1Mg/Ml 3Ml Solution Ophthalmic Use
05 1Bismuth Oxide+Metronidazole+Tetracycline Hydrochloride 140+125+125Mg 120 Unita' Oral Use
06 1Brimonidine 0.2% 5Ml Solution Ophthalmic Use
07 2CAPSULE
08 17CAPSULE, EXTENDED RELEASE;ORAL
09 3CAPSULE;ORAL
10 7CREAM;TOPICAL
11 1CREAM;VAGINAL
12 2Capsule, hard
13 1Dexamethasone 700Mcg 1 Units Use Intravitreale
14 1EMULSION; OPHTHALMIC
15 6EYE DROPS, SOLUTION
16 4EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINERS
17 14Eye drops, resolution
18 1FILM, EXTENDED RELEASE;TRANSDERMAL
19 2GEL
20 1GEL, METERED;TRANSDERMAL
21 5GEL;TOPICAL
22 3INJECTABLE;INJECTION
23 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
24 1INTRAVITREALT IMPLANTAT I APPLIKATOR
25 1Injection fluid, resolution
26 1Intrauterine Posts
27 1Intravitrealt implant in applicator
28 1LOTION/SHAMPOO;TOPICAL
29 1Levobunolol 0.5% 0.4 Ml 60 Units Solution Ophthalmic Use
30 1Levobunolol 0.5% 5Ml Solution Ophthalmic Use
31 6OINTMENT;OPHTHALMIC
32 2OINTMENT;TOPICAL
33 3OPD
34 3POWDER FOR SOLUTION FOR INJECTION
35 1PULVER TILL INJEKTIONSVÄTSKA, LÖSNING
36 21SOLUTION/DROPS;OPHTHALMIC
37 1SOLUTION;ORAL
38 2SOLUTION;TOPICAL
39 3SUSPENSION/DROPS;OPHTHALMIC
40 2SUSPENSION;OPHTHALMIC
41 1SYRUP;ORAL
42 1TABLET (EXTENDED-RELEASE)
43 17TABLET;ORAL
44 2TABLET;ORAL-21
45 2TABLET;ORAL-28
46 3TABLET;SUBLINGUAL
47 1Timolol+Bimatoprost 300Mcg/Ml+5Mg/Ml 30 Joined' Solution Ophthalmic Use
48 1Timolol+Bimatoprost 900Mcg+15Mg Solution Ophthalmic Use
49 1Timolol+Bromonidine 0.2%+0.5% 5Ml Solution Ophthalmic Use
50 5VIAL; SINGLE-USE
51 14Blank
Reset all filters
01 2-
02 20.01%
03 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
04 10.0125MG;0.0031MG
05 30.025%
06 10.025MG;0.0063MG
07 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
08 20.035MG;0.5MG
09 20.035MG;1MG
10 10.0375%
11 30.05%
12 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
13 10.05MG;0.0125MG
14 10.075%
15 10.1 MG / ML
16 20.1 mg/ml
17 60.1%
18 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 10.1%;10%
20 10.12%;0.1%
21 10.15MG;0.0375MG
22 10.1MG;0.025MG
23 10.2% (2 MG / ML)
24 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
25 20.2%;10%
26 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 10.25MG;0.0625MG
28 20.3 MG / ML
29 20.3 MG / ML + 5
30 40.3 mg/ml
31 40.3 mg/ml/5 mg/ml
32 20.3%
33 10.5 MG / ML
34 60.5%
35 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 51%
37 11%;0.5%
38 110 mg/ml
39 210%
40 110,000 UNITS/ML;EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
41 1100 ALLERGAN
42 2100 UNITS/VIAL
43 1100MG
44 210MG
45 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
46 1120 cps 140 mg + 125 mg + 125 mg
47 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
48 1125MG
49 1125MG/ML
50 1130MG
51 1150MG
52 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
53 11mg/g
54 12 MG / ML + 5 MG / ML
55 22 mg/ml
56 22 mg/ml/5 mg/ml
57 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
58 22.5%
59 120 mcg/24 hours
60 1200 ALLERGAN
61 1200 UNITS/VIAL
62 1200MG
63 120MG
64 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
65 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
66 1250MG
67 1250MG/ML
68 125MG
69 2290 mcg
70 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
71 13%
72 13.9MG/24HR
73 130%
74 130MG
75 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
76 1325MG;50MG;40MG;30MG
77 14
78 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
79 140 Monod Coll 0.4 Ml 0.03%
80 1400MG
81 140MG
82 150 ALLERGAN UNITS
83 250 UNITS/VIAL
84 1500MG
85 150MG
86 45mg/ml
87 160MG
88 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
89 1700 MIKROGRAM
90 1700 mcg
91 170MG
92 180MG
93 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
94 1Coll 10 Ml 0.3%
95 1Coll 10 Ml 0.5%
96 2Coll 10 Ml 1%
97 1Coll 10 Ml 2%
98 1Coll 3 Ml 0.2%
99 1Coll 3 Ml 1%
100 1Coll 5 Ml 0,5 Mg/Ml
101 1Coll 5 Ml 0.1%
102 1Coll 5 Ml 0.5%
103 1Coll Bottle Groun 0.005% + Plug Solv 7 Ml
104 1EQ 0.3% BASE
105 1EQ 0.3% BASE;0.6%
106 1EQ 0.3% BASE;1%
107 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
108 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
109 2EQ 10MG BASE
110 3EQ 2.5MG BASE
111 1EQ 2.5MG BASE/5ML
112 1EQ 20MG BASE
113 3EQ 5MG BASE
114 1EYE DROPS 3 ML 300 mcg/ml + 5 mg/ml
115 1EYE DROPS 3 ml 0,3 mg/ml
116 1EYE DROPS 3 ml 0. 1 mg/ml
117 1EYE DROPS 5 ml 0.2% + 0.5%
118 1EYE DROPS 5 ml 2 mg/ml
119 1EYE DROPS 5 ml 5 mg/ml
120 1Pom Oftalm 3,5 G 0,3%
121 1Ung Oftalm 3 G 0,2%
122 1collyrium 30 monodose containers 0.4 ml 300 mcg/ml + 5 mg/ml
123 1collyrium 30 monodose vials 0.4 ml 0,3 mg/ml
124 1collyrium 60 monodose vials 0.4 ml 5 mg/ml
125 1intravitreale implant 700 mcg + applicator
Reset all filters
01 3Canada
02 25Italy
03 19Norway
04 5South Africa
05 15Sweden
06 110USA
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 25MG
Packaging : 30
Approval Date :
Application Number : 2070863
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 10MG
Packaging : 30
Approval Date :
Application Number : 2070847
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Packaging :
Approval Date : 2015-03-12
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 1990-10-26
Application Number : 19429
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 0.5% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 1% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy